LONDON (Reuters) - British pharmaceutical company BTG announced two deals on Thursday that it said could create an interventional medicine business with potential sales of $1 billion. Chief Executive ...
Thomas Kolaras has been named chief commercial officer, U.S., for SERB and BTG Specialty Pharmaceuticals, the companies said Monday. Kolaras brings more than 25 years of U.S. and global experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback